<- Zur Startseite

Makers of GLP-1 drugs ordered to add warnings about rare eye condition that can lead to blindness

Quelle: BBC World - Veroeffentlicht: 10 Nov 2026 21:43

The US Food and Drug Administration says Ozempic, Wegovy, and other weight-loss drugs must have labels about the condition, known as NAION.